Related Experiment Video
Updated: Mar 29, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Structural Modification of Selected Essential Oil Components for Potential Anticancer Applications: A Review
Vuyolwethu Khwaza1, Vuyani Maqanda1
1Department of Earth and Chemical Sciences, Chemistry Discipline, University of Fort Hare, Alice 5700, Eastern Cape, South Africa.
Structural modification of essential oil compounds enhances their anticancer potential. Strategies like hybridization and heterocycle incorporation show promise, but further validation is needed for clinical use.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Oncology
Background:
- Essential oils (EOs) contain bioactive compounds like monoterpenes and phenylpropanoids with anticancer properties.
- Direct therapeutic application of these natural compounds is limited by poor bioavailability, potency, and specificity.
Purpose of the Study:
- To review structural modification strategies for enhancing the anticancer activity of EO components.
- To evaluate the impact of these modifications on potency and mechanisms of action.
Main Methods:
- Pharmacophore hybridization
- Heterocycle incorporation (triazoles, oxadiazoles, chalcones)
- Esterification, halogenation, metal complexation, and nanoparticle conjugation
Main Results:
- Structural modifications significantly improve the anticancer potential of EO scaffolds.
- Different strategies offer varying degrees of enhancement across diverse EO components.
- Evidence base is heterogeneous, limiting direct comparisons and translational interpretation.
Conclusions:
- Structural modification of EO components is a promising strategy for novel anticancer drug discovery.
- Standardized biological evaluation, in vivo validation, and pharmacokinetic/toxicity profiling are crucial for clinical translation.
More Related Videos
Related Concept Videos
Aromatic Compounds: Overview
In 1825, Faraday isolated...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Mutagenicity and Carcinogenicity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules

